Regio- and stereo-selective synthesis of vinyl glucose ester catalyzed by an alkaline protease of Bacillus subtilis

The transesterification of -d-glucose with divinylsuccinate, divinyladipate and divinylsebacate in pyridine at 55 °C for 3 days was catalyzed by an alkaline protease from Bacillus subtilis to give corresponding 6-O-vinyl glucose esters at 30%, 53% and 35% yield, respectively. The stereo-selectivity of the alkaline protease toward the -anomer was affected by the acyl donor chain length. 6-O-Vinylsuccinyl-d-glucose was mixture of - and -anomers (/=44/56), the other two products were the pure -d-glucose derivatives.     

Structure insights into mechanisms of ATP hydrolysis and the activation of human heat-shock protein 90

The activation of molecular chaperone heat-shock protein 90 (Hsp90) is dependent on ATP binding and hydrolysis, which occurs in the N-terminal domains of protein. Here, we have determined three crystal structures of the N-terminal domain of human Hsp90 in native and in complex with ATP and ATP analog, providing a clear view of the catalytic mechanism of ATP hydrolysis by Hsp90. Additionally, the binding of ATP leads the N-terminal domains to be an intermediate state that could be used to partially explain why the isolated N-terminal domain of Hsp90 has very weak ATP hydrolytic activity.     

Analysis of metabolic pathway using hybrid properties

Given a compounds-forming system, i.e., a system consisting of some compounds and their relationship, can it form a biologically meaningful pathway? It is a fundamental problem in systems biology. Nowadays, a lot of information on different organisms, at both genetic and metabolic levels, has been collected and stored in some specific databases. Based on these data, it is feasible to address such an essential problem. Metabolic pathway is one kind of compounds-forming systems and we analyzed them in yeast by extracting different (biological and graphic) features from each of the 13,736 compounds-forming systems, of which 136 are positive pathways, i.e., known metabolic pathway from KEGG; while 13,600 were negative. Each of these compounds-forming systems was represented by 144 features, of which 88 are graph features and 56 biological features. "Minimum Redundancy Maximum Relevance" and "Incremental Feature Selection" were utilized to analyze these features and 16 optimal features were selected as being able to predict a query compounds- forming system most successfully. It was found through Jackknife cross-validation that the overall success rate of identifying the positive pathways was 74.26%. It is anticipated that this novel approach and encouraging result may give meaningful illumination to investigate this important topic.     

Solution structure and dynamics of human metallothionein-3 (MT-3)

Alzheimer's disease is characterized by progressive loss of neurons accompanied by the formation of intraneural neurofibrillary tangles and extracellular amyloid plaques. Human neuronal growth inhibitory factor, classified as metallothionein-3 (MT-3), was found to be related to the neurotrophic activity promoting cortical neuron survival and dendrite outgrowth in the cell culture studies. We have determined the solution structure of the alpha-domain of human MT-3 (residues 32-68) by multinuclear and multidimensional NMR spectroscopy in combination with the molecular dynamic simulated annealing approach. The human MT-3 shows two metal-thiolate clusters, one in the N-terminus (beta-domain) and one in the C-terminus (alpha-domain). The overall fold of the alpha-domain is similar to that of mouse MT-3. However, human MT-3 has a longer loop in the acidic hexapeptide insertion than that of mouse MT-3. Surprisingly, the backbone dynamics of the protein revealed that the beta-domain exhibits similar internal motion to the alpha-domain, although the N-terminal residues are more flexible. Our results may provide useful information for understanding the structure-function relationship of human MT-3.     

Novel nonapeptide GLP (28–36) amide derivatives with improved hypoglycemic and body weight lowering effects

Glucagon-like peptide-1 (GLP-1) has emerged as a major therapeutic target for the treatment of type 2 diabetes. The nonapeptide GLP-1 (28–36) amide is one of the biological C-terminal products of GLP-1 modified by the neutral endopeptidase (NEP) 24.11 with limited hypoglycemic activity. In this study, we focused on the modification of GLP-1 (28–36) amide for the first time and synthesized a series of GLP-1 (28–36) amide analogues. Results of biological activity evaluation in INS-1 cell, STZ-induced diabetic and diet induced obesity (DIO) mice indicated that S3 as a promising candidate to treat type 2 diabetes and obesity.     

小麦eIF3c基因片段的克隆及序列分析

根据真核翻译起始因子eIF3c的保守序列,搜索小麦EST,由拼接的序列设计引物,从普通小麦‘川麦107'幼苗总RNA中克隆出1102bp的小麦eIF3c1基因片段命名为WeIF3c1.序列分析表明,该片段推断的氨基酸序列与两个拟南芥、水稻、甜樱桃、人类、线虫、老鼠等物种的真核翻译起始因子eIF3c相比较同源性分别为69、61%、85%、72%、38%、36%和38%.     

星球藻属一新种

本文发表了星球藻属一新种,即高山星球藻Asterocapsa alpina Cheng et Cai,sp.nov.。     

残缺类囊体膜与嵴膜小囊的融合膜结构观察

观察了菠菜叶绿体类囊体膜与残缺膜的表面结构及鼠肝线粒体嵴膜小囊在制备过程中的生成过程,证明了嵴膜小囊可有两种,F_1在膜外侧或膜内侧,它们都可与残缺膜组成镶嵌膜,进行光下磷酸化功能。而F_1在膜外侧的嵴膜小囊与残缺膜的嵌合膜活力更高。     

高粱泡的生长调控与结实状况

高粱泡(Rubus lambertionus Ser.)是一种有利用价值的野生果树资源。其优点为:(1)结果早,产量高,亩产量可达500kg以上;(2)适应性广,耐瘠薄,是开发利用低山丘陵的优良资源植物;(3)果实营养丰富,酸味纯正,尤其是所含红色素稳定性好,是加工果汁饮料的优质添加剂;(4)果实采收期在11月中旬到12月底,此时气温低,有利于浆果加工和贮藏,并可利用农闲季节的劳动力。上述特点表明,高粱泡有很好的开发利用前景。但本种在野生状态下蔓生性强,多刺,并具有枝顶生根的习性,因而树形紊乱而松散,栽培时搭架困难,植株占地面积大,而单位面积产量不易提高。为了便于操作管理和提高产量,减少栽培成本,增进经济效益,我们于1990～1991年进行了生长和株形调控试验,